In March 2023, for instance, Aptamer Group plc, a UK-based biotechnology company, launched Optimer-Fc, a new reagent solution for automated immunohistochemistry IHC workflows.

The global immunohistochemistry (IHC) market is experiencing steady growth, with a compound annual growth rate (CAGR) of approximately 7-8%. This expansion is largely driven by the increasing ...

Automated income tax refund system: FBR fails to implement IHC judgement Instead of embracing automation and transparency as directed by the IHC, some FBR officials are playing a hide-and-seek ...

Can a fully automated artificial intelligence (AI)–based human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scoring solution in breast cancer aid general surgical pathologists ...

High-throughput automated IHC platforms are utilized in research to ensure consistent staining across slides, crucial for studying drug effects on tissues at the molecular level.

The Global Immunohistochemistry Market Size was Valued at USD 2.60 Billion in 2023, the Worldwide Immunohistochemistry Market Size is Expected to Reach USD 4.84 Billion by 2033, according to a ...

Aptamer Group plc announces that it has developed a new reagent, Optimer®-Fc, for use in automated immunohistochemistry (IHC) workflows.